Jardea Diagnoses
Mouse and Rat Leptin ELISA |
|||
GWB-95C312 | GenWay Biotech | ELISA_Kits | Ask for price |
Giardia Elisa Laboratories manufactures the jardea diagnoses reagents distributed by Genprice. The Jardea Diagnoses reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact giardia elisa. Other Jardea products are available in stock. Specificity: Jardea Category: Diagnoses
True Blue |
||
TargetMol Chemicals | 1mg | Ask for price |
|
||
Description: True Blue |
True Blue |
||
TargetMol Chemicals | 50mg | Ask for price |
|
||
Description: True Blue |
True Blue |
||
TargetMol Chemicals | 5mg | Ask for price |
|
||
Description: True Blue |
Porcine True insulin ELISA kit |
||
BlueGene | 96T | EUR 700 |
Description: ELISA |
Goat True insulin ELISA kit |
||
BlueGene | 96T | EUR 700 |
Description: ELISA |
Rabbit True insulin ELISA kit |
||
BlueGene | 96T | EUR 700 |
Description: ELISA |
Canine True insulin ELISA kit |
||
BlueGene | 96T | EUR 700 |
Description: ELISA |
Human Multiple Myeloma Bone Marrow Mononuclear Cells (Newly Diagnosed) |
|||
ABC-TC3945 | AcceGen | 1 vial | Ask for price |
|
|||
Description: Multiple Myeloma-Bone Marrow-Mononuclear Cells are isolated by diluting Multiple Myeloma-bone marrow with phosphate-buffered saline and using gradient separation. Multiple Myeloma Bone Marrow-Mononuclear Cells products are available in both the newly diagnosed and relapsed/refractory stages. |
Human Acute Lymphoid Leukemia Bone Marrow Plasma (Newly Diagnosed/Untreated) |
|||
ABC-TC3006 | AcceGen | 1 vial | Ask for price |
|
|||
Description: Acute Lymphoid Leukemia Bone Marrow plasma is obtained by centrifugation of the Acute Lymphoid Leukemia-bone marrow. This product has a diminished number of cells and platelets. Acute Lymphoid Leukemia plasma are available in the newly diagnosed and relapsed/refractory stages. |
Human Acute Myeloid Leukemia Bone Marrow CD34+ Cells (Newly Diagnosed/Untreated) |
|||
ABC-TC3014 | AcceGen | 1 vial | Ask for price |
|
|||
Description: Acute Myeloid Leukemia-Bone Marrow-CD34+ cells are selected from adult Acute Myeloid Leukemia-Bone Marrow-Mononuclear Cells. The Bone Marrow-CD34+ stem/progenitor cells are positively isolated using a direct immunomagnetic CD34 MicroBead labeling system. Acute Myeloid LeukemiaCD34+ cells are available in the newly diagnosed and relapsed/refractory stages. |
Human Acute Myeloid Leukemia Bone Marrow Mononuclear Cells (Newly Diagnosed) |
|||
ABC-TC3016 | AcceGen | 1 vial | Ask for price |
|
|||
Description: Bone Marrow is obtained from adult Acute Myeloid Leukemia patients. Bone Marrow-Mononuclear Cells are isolated by diluting the bone marrow with phosphate-buffered saline and using gradient separation techniques. After centrifugation, the Mononuclear Cells layer is collected. Mononuclear Cells can be processed further to isolate cell subpopulations. Acute Myeloid Leukemia-Mononuclear Cells are available in the newly diagnosed and relapsed/refractory stages. |
Human Acute Myeloid Leukemia Bone Marrow Plasma (Newly Diagnosed/Untreated) |
|||
ABC-TC3019 | AcceGen | 1 vial | Ask for price |
|
|||
Description: Acute Myeloid Leukemia-Bone Marrow Plasma is obtained by centrifugation of the adult Acute Myeloid LeukemiaBone Marrow. Plasma has a diminished number of cells and platelets. Acute Myeloid Leukemia plasma is available in the newly diagnosed and relapsed/refractory stages. |
Human Chronic Myeloid Leukemia Peripheral Blood Marrow (Newly Diagnosed) |
|||
ABC-TC3365 | AcceGen | 1 vial | Ask for price |
|
|||
Description: Chronic Myeloid Leukemia (Chronic Myeloid Leukemia) is often divided into three phases, based on clinical characteristics and laboratory findings. In the absence of interventions, Chronic Myeloid Leukemia typically begins in the chronic phase (85% of Chronic Myeloid Leukemia patients). Over the course of several years, the cancer progresses to an accelerated phase and ultimately to a blast crisis phase. |
Human Acute Lymphoid Leukemia Bone Marrow CD19+ B Cells (Newly Diagnosed/Untreated) |
|||
ABC-TC3001 | AcceGen | 1 vial | Ask for price |
|
|||
Description: Acute Lymphoid Leukemia-Bone Marrow-CD19+ B cells are positively isolated from adult Acute Lymphoid Leukemia-Bone MarrowMononuclear Cells, using a direct immunomagnetic CD19 MicroBead labeling system. These CD19+ B cells are are available in newly diagnosed and relapsed/refractory stages. |
Human Acute Lymphoid Leukemia Bone Marrow Mononuclear Cells (Newly Diagnosed) |
|||
ABC-TC3003 | AcceGen | 1 vial | Ask for price |
|
|||
Description: Bone Marrow is obtained from adult Acute Lymphoid Leukemia patients. Bone Marrow-Mononuclear Cells are isolated from bone marrow by diluting the whole bone marrow with phosphate buffered saline and using gradient separation techniques. Mononuclear Cells can be processed to isolate subpopulations. Acute Lymphoid Leukemia-Bone Marrow-Mononuclear Cells are available in the newly diagnosed and relapsed/refractory stages. |
Human Chronic Lymphoid Leukemia Bone Marrow Plasma (Newly Diagnosed/Untreated) |
|||
ABC-TC3344 | AcceGen | 1 vial | Ask for price |
|
|||
Description: Chronic Lymphoid Leukemia Bone Marrow-Plasma is obtained by centrifugation of the Chronic Lymphoid Leukemia bone marrow. Plasma has a diminished number of cells and platelets. Chronic Lymphoid Leukemia plasma is available in untreated and relapsed/refractory stages. |
Human Diffuse Large B-Cell Lymphoma Bone Marrow Plasma (Newly Diagnosed/Untreated) |
|||
ABC-TC3405 | AcceGen | 1 vial | Ask for price |
|
|||
Description: Diffuse Large B-Cell Lymphoma-PB-Plasma is obtained by centrifugation of peripheral blood tissue. Diffuse Large B-Cell Lymphoma Plasma is available in the untreated and relapsed/refractory stages. |
Human Chronic Lymphoid Leukemia Bone Marrow CD19+/CD5+ B Cells (Newly Diagnosed/Untreated) |
|||
ABC-TC3339 | AcceGen | 1 vial | Ask for price |
|
|||
Description: Chronic Lymphoid Leukemia-PB-CD19+/CD5+ B cells are isolated from Chronic Lymphoid Leukemia bone marrow mononuclear cells using a direct immunomagnetic CD19+ Micro- Bead labeling system. Available in untreated or relapsed/refractory stages.CD5 co-expression on Bone Marrow-CD19+ B Cells can be used as a strong indicator of Chronic Lymphoid Leukemia infiltration in the bone marrow. In many untreated or lower-staged Chronic Lymphoid Leukemia cases, the co-expression level of CD5 in Bone Marrow-CD19+ cells is significantly lower than the co-expression level within peripheral blood. |
Human Multiple Myeloma Bone Marrow Mononuclear Cells (Newly Diagnosed/Untreated) |
|||
ABC-TC3946 | AcceGen | 1 vial | Ask for price |
|
|||
Description: Multiple Myeloma-Bone Marrow-Mononuclear Cells are isolated by diluting Multiple Myeloma-bone marrow with phosphate-buffered saline and using gradient separation. Multiple Myeloma Bone Marrow-Mononuclear Cells products are available in both the newly diagnosed and relapsed/refractory stages. |
Human Acute Myeloid Leukemia Peripheral Blood Mononuclear Cells (Newly Diagnosed) |
|||
ABC-TC3028 | AcceGen | 1 vial | Ask for price |
|
|||
Description: PBMCs are isolated from Acute Myeloid Leukemia-PB by diluting the blood with phosphate-buffered saline and using gradient separation techniques. After centrifugation, the Mononuclear Cells layer is collected. Acute Myeloid Leukemia Peripheral Blood Mononuclear Cells are available in the newly diagnosed and relapsed/refractory stages. |
Human Mantle Cell Lymphoma Bone Marrow Mononuclear Cells (Newly Diagnosed/Untreated) |
|||
ABC-TC3885 | AcceGen | 1 vial | Ask for price |
|
|||
Description: Mantle Cell Lymphoma-Bone Marrow-Mononuclear Cells are density separated by Ficoll-Paque to enrich mononuclear cells. Mantle Cell Lymphoma BMMCs are available in untreated and relapsed/refractory stages. |
Human Acute Lymphoid Leukemia Bone Marrow Mononuclear Cells (Newly Diagnosed/Untreated) |
|||
ABC-TC3004 | AcceGen | 1 vial | Ask for price |
|
|||
Description: Bone Marrow is obtained from adult Acute Lymphoid Leukemia patients. Bone Marrow-Mononuclear Cells are isolated from bone marrow by diluting the whole bone marrow with phosphate buffered saline and using gradient separation techniques. Mononuclear Cells can be processed to isolate subpopulations. Acute Lymphoid Leukemia-Bone Marrow-Mononuclear Cells are available in the newly diagnosed and relapsed/refractory stages. |
Human Acute Myeloid Leukemia Bone Marrow Mononuclear Cells (Newly Diagnosed/Untreated) |
|||
ABC-TC3017 | AcceGen | 1 vial | Ask for price |
|
|||
Description: Bone Marrow is obtained from adult Acute Myeloid Leukemia patients. Bone Marrow-Mononuclear Cells are isolated by diluting the bone marrow with phosphate-buffered saline and using gradient separation techniques. After centrifugation, the Mononuclear Cells layer is collected. Mononuclear Cells can be processed further to isolate cell subpopulations. Acute Myeloid Leukemia-Mononuclear Cells are available in the newly diagnosed and relapsed/refractory stages. |
Human Chronic Lymphoid Leukemia Bone Marrow Mononuclear Cells (Newly Diagnosed/Untreated) |
|||
ABC-TC3342 | AcceGen | 1 vial | Ask for price |
|
|||
Description: Chronic Lymphoid Leukemia-Bone Marrow-Mononuclear Cells are isolated by diluting Chronic Myeloid Leukemia bone marrow with phosphate-buffered saline and using gradient separation techniques. After centrifugation, the Mononuclear Cells layer is collected. Chronic Lymphoid LeukemiaBone Marrow- Mononuclear Cells can be processed further to isolate subpopulations. They are available in either untreated or relapsed/refractory stages. |